Explore PATH stock price, Q3 earnings beat, technical, valuation vs ZS CRM, analyst targets. Is PATH stock a buy amid AI agent push? Key insights.
Introduction
UiPath builds robotic process automation software. It automates repetitive tasks with AI agents for businesses. PATH stock draws attention after first GAAP profit and agentic AI launches.
Tech sector cools on AI hype fatigue. Yet RPA demand grows in efficiency drives. PATH stock fits automation bets.
Latest Stock Price & Trend
PATH closed $12.48 Friday, after hours $10.73 up 0.14%. Volume 50M above avg 30M. Day low $10.17 high $10.83.
5-day -5.60%, 1-month -3.78%. 3-month +26.44%, 6-month -3.78%. YTD -3.48%. 52-week low $9.38 high $19.84.
Trend sideways near MAs. Investors see stabilization but watch macro drags.
Technical Analysis
Support $10-11 near year low. Resistance $13-14. Key for entry/exit points.
RSI 54.39 neutral. MACD flat.
50-day MA $12.69, 200-day $12.71—no cross. Volume decreasing signals caution.
Analyst Ratings & Price Targets
16% Buy, avg target $14-15, high $20 low $10. RBC cut post-caution. Mixed on AI ramp.
Sentiment cautious; aids value plays.
Insider Activity
Awards Ashim Gupta 288k, Brad Brubaker 146k Feb 25. Daniel Dines sold 122k Sep 2025.
Grants routine, sales planned. Neutral signal.
Valuation Analysis
Trailing P/E 25.55. Q3 revenue $411M +16% YoY beat, EPS $0.03. Cash $1.4B no debt. FCF positive $370M FY guide.
Vs ZS (higher P/S), CRM—undervalued on growth/profit shift.
Recent Earnings & Catalysts
Q3 revenue $411M beat $393M, EPS $0.03 vs $0.14. First GAAP profit $13M op income. Q4 $462-467M guide.
Agent Builder 950 cos, Maestro 365k processes. Partnerships MSFT OpenAI. Stock +0.24%.
Bullish Case
Agentic AI sticks customers. ARR $1.78B +11%. Margins to 21% non-GAAP.
Bearish Case
AI revenue FY26 nil. Public sector delays. Retention 107% modest.
Market Sentiment
Institutions Vanguard 49M shares. Short low. Neutral optimistic tilt.
Short-Term Outlook
Neutral RSI, low volume. Range-bound likely.
Medium to Long-Term Outlook
RPA+AI model solid. Accumulate on dips for FY27 AI.
FAQ
Is PATH stock a buy right now? Possible undervalued; watch AI traction.
PATH stock price target? Avg $15, high $20.
PATH forecast? ARR $1.84B Q4.
Major risks for PATH stock? AI delays, macro.
PATH technical analysis? Sideways, RSI 54.
Suggestions
Compare with Opendoor
See ServiceNow forecast.
Read RPA sector breakdown.
Final Balanced Conclusion
Watchlist PATH stock. Profit gains strong but AI ramp slow; undervalued potential.
Disclaimer: This article is for informational purposes only and not financial advice.